1. Home
  2. BNTC vs VREX Comparison

BNTC vs VREX Comparison

Compare BNTC & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • VREX
  • Stock Information
  • Founded
  • BNTC 1995
  • VREX 2016
  • Country
  • BNTC United States
  • VREX United States
  • Employees
  • BNTC N/A
  • VREX N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • VREX Industrial Machinery/Components
  • Sector
  • BNTC Health Care
  • VREX Technology
  • Exchange
  • BNTC Nasdaq
  • VREX Nasdaq
  • Market Cap
  • BNTC 335.5M
  • VREX 443.9M
  • IPO Year
  • BNTC N/A
  • VREX N/A
  • Fundamental
  • Price
  • BNTC $13.24
  • VREX $11.55
  • Analyst Decision
  • BNTC Strong Buy
  • VREX Strong Buy
  • Analyst Count
  • BNTC 5
  • VREX 2
  • Target Price
  • BNTC $26.00
  • VREX $19.50
  • AVG Volume (30 Days)
  • BNTC 40.8K
  • VREX 545.0K
  • Earning Date
  • BNTC 09-25-2025
  • VREX 08-07-2025
  • Dividend Yield
  • BNTC N/A
  • VREX N/A
  • EPS Growth
  • BNTC N/A
  • VREX N/A
  • EPS
  • BNTC N/A
  • VREX N/A
  • Revenue
  • BNTC N/A
  • VREX $821,400,000.00
  • Revenue This Year
  • BNTC N/A
  • VREX $5.01
  • Revenue Next Year
  • BNTC N/A
  • VREX $2.97
  • P/E Ratio
  • BNTC N/A
  • VREX N/A
  • Revenue Growth
  • BNTC N/A
  • VREX N/A
  • 52 Week Low
  • BNTC $8.06
  • VREX $6.76
  • 52 Week High
  • BNTC $17.15
  • VREX $16.93
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 59.72
  • VREX 76.25
  • Support Level
  • BNTC $12.57
  • VREX $11.22
  • Resistance Level
  • BNTC $13.33
  • VREX $11.51
  • Average True Range (ATR)
  • BNTC 0.60
  • VREX 0.49
  • MACD
  • BNTC 0.10
  • VREX 0.05
  • Stochastic Oscillator
  • BNTC 95.59
  • VREX 82.53

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About VREX Varex Imaging Corporation

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.

Share on Social Networks: